Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lipid biomarkers in urine can determine the type of asthma

In a new study, researchers at Karolinska Institutet in Sweden have used a urine test to identify and verify a patient’s type of asthma. The study, which has been published in the American Journal of Respiratory and Critical Care Medicine, lays the foundation for a more personalized diagnosis and may result in improved treatment of severe asthma in the future.About 10 percent of the Swedish population suffers from asthma, a disease that has become increasingly widespread over the past 50 years, with annual global mortality of around 400,000 according to the World Health Organization. Asthma

Resolutions at the extraordinary general meeting in Medivir on 13 January 2021

Resolution regarding reduction of the share capital without cancellation of shares The extraordinary general meeting in Medivir Aktiebolag (publ) on 13 January 2021 resolved, in accordance with the board of directors’ proposal, to decrease the company’s share capital with SEK 20,908,234.356976 without cancellation of shares. The reduction of the share capital was conducted in order to enable the resolution on the share issue. It was also resolved to authorize the CEO to make such minor adjustments to this resolution that may be necessary in connection with the registration thereof.

FluoGuide gets green light to proceed to third dose level with FG001 in the ongoing clinical phase I/II trial in patients with high grade glioma

Copenhagen, Denmark, 13 January 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the dose escalation committee has approved initiation of the third dose levelin the ongoing clinical phase I/II trial evaluating safety and efficacy of FG001 in patients with high grade glioma undergoing neurosurgery.Evaluation of the results from the second dose level of FG001, including data from three patients, has been finalized and reported to the dose escalation committee. The dose escalation committee has today given their approval to proceed and enroll patients at the

Selvaag Bolig ASA: New CFO for Selvaag Bolig

Christopher Brunvoll has been appointed the new CFO for Selvaag Bolig. Currently CEO of Urban Property Management AS, he has previously served as Selvaag Bolig’s chief controller. “We’ve pursued a broad-based recruitment process, with many highly competent applicants,” reports CEO Sverre Molvik. “After a careful evaluation, our choice fell on the candidate who knows both the sector and company best. “Brunvoll possesses valuable expertise and experience which are important and right for us, and will unquestionably help to strengthen our company even further.” Born in 1977, Brunvoll

Johan Menckel strengthens Latour's management

It is with great joy we can announce that Johan Menckel has accepted the offer to become Executive Vice President and Chief Investment Officer of Latour. Latour has had a strong growth for a long time. Given this, a natural next step is to adapt and strengthen the organisation to enable continued growth in combination with active ownership and delegated organisation, which is close to Latour’s heart. Johan Menckel has a long industrial and international experience from, among others, Asia and the US, which means that he has a good match with Latour as a long-term principal owner in large

Gränges’ CEO and President Johan Menckel has informed the Board that he has decided to leave his position after 8 years. He will remain in his role until 1 August, 2021.

“After 18 years within Gränges, of which the last 8 years as CEO, Johan has chosen to take on another position. Johan is an appreciated leader who has made a powerful contribution to Gränges’ development to a strong position. We want to thank him for his good achievements and look forward to further cooperation until 1 August, and also wish Johan good luck in his new role,” says Fredrik Arp, Chairman of the Board, Gränges AB. “After a long, eventful and very stimulating period, it has been a difficult decision to make, but I am also looking forward to moving on to new challenges in a new

Simon-Kucher Appoints Seven New Partners in the Life Sciences Sector and Expands Thought Leadership

The Healthcare and Life Sciences division at consultancy Simon-Kucher & Partners continues to grow: By announcing seven new partners, the international team increases its presence in several healthcare subsectors around the globe.Jan. 13, 2021 – The global strategy and marketing consultancy Simon-Kucher & Partners has elected seven new partners in its Healthcare and Life Sciences practice from Europe, the USA, and Asia. Now with a total of 41 partners, the division advises companies in multiple healthcare subsectors, including pharmaceutical and biotech, healthtech, and consumer health.

Nolato nominates new Board member and re-elects current members

Nolato’s Nomination Committee will nominate Tomas Blomquist as a new member of the Board ahead of the company’s 2021 AGM. Tomas Blomquist, born 1970, has in-depth knowledge and wide-ranging experience within the field of health care, with a focus on diagnostics and medical technology, and over the past two decades has held a number of senior management positions in both global and regional companies. Since 2019 Tomas has been President and CEO of Biotage, which provides solutions for customer workflows in pharmaceutical research and manufacturing, as well as analytical testing and water and

Statement of the Board of Directors of Tikkurila Oyj regarding the recommended voluntary public cash tender offer by PPG Industries, Inc.

Statement of the Board of Directors of Tikkurila Oyj regarding the recommended voluntary public cash tender offer by PPG Industries, Inc. TIKKURILA OYJTender OfferJanuary 13, 2021 at 11.05 a.m. EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. On December 18, 2020, PPG Industries, Inc. (the “Offeror” or “PPG”) and Tikkurila Oyj (“Tikkurila” or the “Company”)

Invitation – SEB ’s Annual Accounts 2020

On Wednesday, 27 January, at approximately 07:00 (Swedish time) SEB’s results for the fourth quarter 2020 will be announced. In addition, presentations and the Fact Book will be available on sebgroup.com/ir . You are invited to participate in the following event. Given the current circumstances the results presentation will be held as a telephone conference. Telephone conferenceTime: 09:00 (Swedish time)Johan Torgeby, President and CEO, and Masih Yazdi, CFO, will present and comment upon the results, followed by a Q&A session with Johan Torgeby, Masih

Swedbank Robur’s Russia and Eastern Europe fund excludes oil, coal and gas

Aligned with Swedbank Robur's new Policy for Responsible investments, the focus on sustainability is further sharpened. This means, among other things, that Swedbank Robur's Russia and Eastern Europe Fund's holdings in the energy sector with revenues from fossil fuels have been divested. As of January 1, 2021, the two funds will instead focus on companies in areas such as communications, finance, e-commerce, IT and real estate.Swedbank Robur's Policy for Responsible investments has been updated and supplemented with three new strategies for how the work with including, excluding and

SimCorp A/S - Major shareholder announcement

With reference to Section 30 of Consolidated Act no. 377 of 2 April 2020 on capital markets, please be informed that SimCorp A/S January 12, 2021 was informed by Mawer Investment Management Ltd.. that Mawer Investment Management Ltd. now owns 5.22% of the share capital and voting rights in SimCorp A/S. The shares are traded at NASDAQ Copenhagen A/S. Questions may be addressed to Anders Hjort, VP, Head of Investor Relations, SimCorp A/S (+45 3544 8800). SimCorp A/S

Visma Onguard strengthens market position with acquisition of Outstanding24

Visma Onguard, the fintech company dedicated to the order-to-cash process, today announces the acquisition of Dutch scale-up, Outstanding24, taking over all activities and employees. With Outstanding24, Visma Onguard adds an innovative cloud solution for efficiently organising debtor management for SMEs to its portfolio. This news sees the recently rebranded Visma Onguard strengthening its position in the market whilst enabling Outstanding24 to realise its growth ambition.Anton Maas, director of Outstanding24 comments, "For Outstanding24, the acquisition comes at the right time. About

Asetek A/S Announces Transactions Carried Out Under the Current Share Buyback Programme in Accordance With the "Safe Harbour Method"

January 13, 2021 - On October 23, 2020, Asetek A/S launched a share buyback programme, as described in company announcement of October 23, 2020. According to the programme, Asetek A/S will in the period until March 5, 2021 buy back own shares up to a maximum value of USD 4 million and with a maximum of 381,000 shares. The share buyback programme will be implemented in accordance with Regulation (EU) no. 596/2014 of 16th April 2014 of the European Parliament and Council and  ommission Delegated Regulation (EU) no. 2016/1052, also referred to as the Safe Harbour rules. Trading day

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 10 - 13 JANUARY 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90/2020. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Heimstaden considers issuance of subsequent bonds and announces tender offer for outstanding 2021 notes

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

The Riksbank begins transition to a fully self-financed foreign exchange reserve

The Riksbank is replacing external financing of the foreign exchange reserve by purchasing foreign currency on the foreign exchange market between February 2021 and December 2023. The purchases will take place at an even pace, be paid in Swedish kronor and amount to about SEK 5 billion per month, on average. At the same time, the Riksbank intends to repay the currency loans taken by the Swedish National Debt Office as they mature. This will provide the Riksbank with more appropriate long-term funding for the foreign exchange reserve. This change has no monetary policy purpose.The foreign

Medius and Pagero partner to help businesses efficiently manage e-invoices

Stockholm, 13 January 2021 The newly signed partnership allows Medius and Pagero’s joint customer base receive and process e-invoices in a variety of formats across the globe, supporting local regulatory compliance and efficient financial operations.Medius is a leading provider of cloud-based spend management solutions with a long track record of serving businesses with tools that digitize and automate the accounts payable process. The partnership with global e-document service provider Pagero  allows customers to further consolidate management of all invoice

Organic fertilizers and biogas from biowaste in the Helsinki region – commercial use of the Lohja biogas plant started up

Gasum’s biogas plant on the site of Munkkaa waste center in Lohja will turn biowaste from the Helsinki region into renewable biogas for transport and industry as well as organic fertilizers for agriculture. The plant will process around 60,000 tonnes of biodegradable feedstocks into 40 GWh of biogas and 50,000 tonnes of organic fertilizers a year. The biogas will be injected from the plant straight into the gas network. The plant entered commercial service to plan in January 2021.Gasum strives actively to increase biogas production capacity by building new biogas plants and also by

Ship control redefined: Wärtsilä SmartMove Suite sets sail with the American Steamship Company

Wärtsilä Corporation, Press release, 13 January 2021 at 10:00 AM EET· Wärtsilä launches SmartMove Suite, a unique pairing of sensor tech with navigation systems for semi-autonomous ship movement. · American Steamship Company, a subsidiary of Rand-ASC Holdings LLC, is the first to install Wärtsilä SmartMove solutions for hands-off transit along the Cuyahoga River in Ohio, US. · Great Lakes self-unloading bulk freighter, MV American Courage, with cargo carrying capacity of 24,300 gross tonnage, is the largest ship ever to perform automatic dock-to-dock operation. Wärtsilä Voyage has

Borr Drilling Limited – Update

Borr Drilling Limited (the “Company”) (NYSE and OSE: “BORR”) refers to an article initially published in the Norwegian newspaper “Dagens Næringsliv” today, which refers to a potential alternative plan discussed by two creditors. The Board and Management are highly confident that the Company can execute the liquidity improvement plan and equity raise as announced in a press release on 24 December 2020. The Company is working closely and constructively with all lenders to achieve the best possible solution for all stakeholders. Hamilton, Bermuda 13 January 2021 Forward looking

BioStock: Staybe Therapeutics sees optimism amongst study clinics

During 2020, Stayble Therapeutics, despite the Covid-19-pandemic, managed to initiate a phase IIb study with its candidate STA363 in all the countries intended to be included in the study. The company also carried out an IPO and a successful issue which was subscribed to 436 per cent. In addition, the results from Stayble Therapeutics’ studies with STA363 were published in Spine, a leading scientific journal in the area of spinal research. BioStock has contacted Stayble Therapeutics’ CEO Andreas Gerward to find out more about the past year and the company’s plans for 2021.Read the full

AAK appoints Tomas Bergendahl as new Chief Financial Officer

Tomas Bergendahl has been appointed new Chief Financial Officer of AAK AB (publ.) and will assume his position no later than August 1, 2021. Tomas joins AAK with extensive experience and a solid finance background. For the past five and a half years he has served as CFO and Executive Vice President at COWI Holding A/S, a leading international consulting group within engineering, economics and environmental science based in Denmark. Prior to that, he was CFO at Swedish shipping company Rederi AB TransAtlantic. He has also held various senior finance positions for companies within Volvo

Q-Free: Conversion of convertible bonds

Reference is made to the stock exchange notice 12 January 2021 regarding issuance and registration of new shares following conversion of Q-Free ASA's NOK 80 million unsecured subordinated convertible bond loan (the "Convertible Bond Loan"), for an aggregate principal amount of NOK 67,000,000. Q-Free ASA has now received additional conversion notices from the paying and conversion agent for the Convertible Bond Loan for bonds representing an additional amount of NOK 2,000,000 This will be converted into 550,524 new shares at the conversion price of NOK 3.6329. The aggregated received

There are no items matching the current filter
There are no more items matching the current filter
Back to top